rs1553259691
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1_Very_StrongPM1PM2PM5PP3_ModeratePP5_Moderate
The NM_000530.8(MPZ):c.277G>C(p.Gly93Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G93A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000530.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZ | NM_000530.8 | c.277G>C | p.Gly93Arg | missense_variant | Exon 3 of 6 | ENST00000533357.5 | NP_000521.2 | |
MPZ | NM_001315491.2 | c.277G>C | p.Gly93Arg | missense_variant | Exon 3 of 6 | NP_001302420.1 | ||
MPZ | XM_017001321.3 | c.307G>C | p.Gly103Arg | missense_variant | Exon 3 of 6 | XP_016856810.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease, type I Pathogenic:1
This sequence change replaces glycine with arginine at codon 93 of the MPZ protein (p.Gly93Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with clinical features of Charcot-Marie-Tooth disease (CMT) in an affected family (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Two different missense substitutions at this codon (p.Gly93Ala, p.Gly93Glu) have been reported in individuals affected with Charcot-Marie-Tooth disease (PMID: 21326314, 9217235). These observations suggest that this novel missense substitution at this residue may affect protein function, but this has not been confirmed by published studies and the clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at